CHRISTINA WEIBLEY: Open Payments
NPI 1043941123 · SALEM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 35 payments from 11 companies in 2025. Trend: 2023 $720 · 2024 $725 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 8 | $122 |
| Sage Therapeutics, LLC | 5 | $111 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| Organon LLC | 5 | $78 |
| Astellas Pharma US Inc | 3 | $64 |
| Exeltis, USA Inc. | 4 | $60 |
| Hologic Sales and Service, LLC | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: ZURZUVAE, MYFEMBREE, NEXPLANON, Veozah, SLYND, APTIMA, FABRAZYME, Qelbree.
Industry payments across IL — which companies pay providers there.
